Proinflammatory effects of bacterial lipoprotein on human neutrophil activation status, function and cytotoxic potential in vitro

被引:27
作者
Power, C [1 ]
Wang, JH [1 ]
Sookhai, S [1 ]
Wu, QD [1 ]
Redmond, HP [1 ]
机构
[1] Cork Univ Hosp, Acad Dept Surg, Cork, Ireland
来源
SHOCK | 2001年 / 15卷 / 06期
关键词
CD11b/CD18; CD14; lipopolysaccharide; leukocyte-endothelial interaction; gram-negative bacteria; sepsis;
D O I
10.1097/00024382-200115060-00009
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Bacterial lipoprotein (BLP) is the most abundant protein in gram-negative bacterial cell walls, heavily outweighing lipopolysaccharide (LPS). Herein we present findings demonstrating the potent in vitro effects of BLP on neutrophil (PMN) activation status, function, and capacity to transmigrate an endothelial monolayer. PMNs are the principal effecters of the initial host response to injury or infection and constitute a significant threat to invading bacterial pathogens. The systemic inflammatory response syndrome (SIRS) is characterised by significant host tissue injury mediated, in part, by uncontrolled regulation of PMN cytotoxic activity. We found that BLP-activated human PMN as evidenced by increased CD11b/CD18 (Mac-1) expression. Up-regulation of PMN Mac-1 in response to BLP occurred independently of membrane-bound CD14 (mCD14). A similar up-regulation of intercellular adhesion molecule-1 (ICAM-1) on endothelial cells was observed whilst E-Selectin expression was unaffected. PMN transmigration across a human umbilical vein endothelial cell (HUVEC) monolayer was markedly increased after treating either PMN's or HUVEC independently with BLP. This increased transmigration did not occur as a result of any direct effect of BLP on HUVEC monolayer permeability, assessed objectively using the passage of FITC-labeled Dextran-70. BLP primed PMN for enhanced respiratory burst and superoxide anion production in response to PMA, but did not influence phagocytosis of opsonized Escherichia coli. BLP far exceeds LPS as a gram-negative bacterial wall component, these findings therefore implicate BLP as an additional putative mediator of SIRS arising from gram-negative infection.
引用
收藏
页码:461 / 466
页数:6
相关论文
共 33 条
[1]  
ABE Y, 1990, J IMMUNOL, V145, P2902
[2]  
BROOKS GF, 1991, MED MICROBIOLOGY, P7
[3]  
CHANOCK SJ, 1994, J BIOL CHEM, V269, P519
[4]   Systemic inflammatory response syndrome [J].
Davies, MG ;
Hagen, PO .
BRITISH JOURNAL OF SURGERY, 1997, 84 (07) :920-935
[5]   Circulating granulocyte macrophage colony-stimulating factor in plasma of patients with the systemic inflammatory response syndrome delays neutrophil apoptosis through inhibition of spontaneous reactive oxygen species generation [J].
Fanning, NF ;
Kell, MR ;
Shorten, GD ;
Kirwan, WO ;
Bouchier-Hayes, D ;
Cotter, TG ;
Redmond, HP .
SHOCK, 1999, 11 (03) :167-174
[6]   SOLUBLE CD14 PARTICIPATES IN THE RESPONSE OF CELLS TO LIPOPOLYSACCHARIDE [J].
FREY, EA ;
MILLER, DS ;
JAHR, TG ;
SUNDAN, A ;
BAZIL, V ;
ESPEVIK, T ;
FINLAY, BB ;
WRIGHT, SD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1665-1671
[7]  
Galdiero M, 1999, CLIN EXP IMMUNOL, V116, P453
[8]   LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN ACCELERATES THE BINDING OF LPS TO CD14 [J].
HAILMAN, E ;
LICHENSTEIN, HS ;
WURFEL, MM ;
MILLER, DS ;
JOHNSON, DA ;
KELLEY, M ;
BUSSE, LA ;
ZUKOWSKI, MM ;
WRIGHT, SD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) :269-277
[9]  
Haziot A, 1995, Prog Clin Biol Res, V392, P349
[10]  
HAZIOT A, 1998, J IMMUNOL, V141, P157